State
73,088 recalls have nationwide distribution and so reach Connecticut. 6,571 additional recalls listed Connecticut specifically in their distribution scope.
Of the 6,571 recalls naming Connecticut we have scored against our rubric, 838 (13%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,590 (24%) are Severe.
Which agencies issued them
These figures cover only the 6,571 recalls whose distribution notice names Connecticut specifically. The 73,088 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Chrysler is recalling specific Mopar rearview camera modules because incorrect software may prevent the image from displaying, increasing crash risk.
Land Rover is recalling certain 2022-2023 Range Rover vehicles because water may enter the rearview camera, blanking or distorting the image. 11,961 units are affected.
Melii Baby silicone spoons for babies can break apart during use, creating a choking hazard. About 85,100 units sold through multiple retailers from April to August 2024 are affected; consumers should stop using them immediately.
Acura is recalling certain 2021-2023 TLX vehicles because the fuel filler neck and fuel tank may have been improperly welded, which can result in a fuel leak.
DesBio lunaSOMM Natural Sleep Support Dietary Supplement is recalled due to undeclared soy lecithin. The product is labeled as containing sunflower lecithin but contains soy lecithin, posing a risk to consumers with soy allergies.
Viatris Inc is recalling 35,883 bottles of Levothyroxine Sodium Tablets (112 mcg) distributed nationwide due to potency failures. Some tablets contain too much active ingredient (superpotent) and others too little (subpotent). No illnesses have been reported.
Volvo is recalling 2023-2024 C40 vehicles because improperly crimped clamps may cause the driver's air bag to deploy improperly, increasing injury risk.
Viatris Inc recalls 92,512 bottles of Levothyroxine Sodium tablets with potency failures—some are stronger than intended, others are weaker than intended.
Noah Medical is recalling Galaxy bronchoscope units due to risk that biopsy tools may require excessive force or fail to pass through the scope channel when the bronchoscope is sharply bent, potentially causing tissue injury or pneumothorax.
Micro-X Ltd. is recalling 18 MICRO-X Rover Mobile X-ray Systems because they can deliver lower radiation doses than operators set. The affected units use Control Board PCBA 12425-03 or earlier.
Microline Surgical is recalling ReNew Microscissor Tip (Disposable) lot 00172110 due to a 2% failure rate where the heat shrink breaks off.
A software issue in the BD Pyxis CII Safe ES automated dispensing cabinet may cause it to open the wrong medication pocket, risking incorrect medication removal or refills.
Mylan Institutional recalls levothyroxine sodium tablets (lot 3115707) due to subpotent and superpotent tablets. The product was distributed nationwide. Consult your healthcare provider.
Viatris Inc is recalling Levothyroxine Sodium Tablets USP 75 mcg due to potency failures affecting approximately 63,077 bottles distributed nationwide in the US and Puerto Rico. Some tablets are superpotent while others are subpotent.
Mercedes-Benz is recalling 2025 E 350, E 350 4MATIC, E 450 4MATIC, and E 450 4MATIC station wagon vehicles due to an improperly welded camber strut bracket on the rear axle carrier that may separate and cause loss of vehicle handling and control.
Mylan Institutional is recalling 1,664 cartons of levothyroxine sodium tablets nationwide due to potency variance. The tablets contain subpotent and superpotent units, affecting the consistency of each dose.
Polestar is recalling certain 2024 Polestar 2 vehicles because clamps on the driver's side air bag module may be improperly crimped, causing the air bag to deploy improperly and reducing crash protection.
Viatris Inc. is recalling Levothyroxine Sodium 200 mcg tablets nationwide due to potency failures—some tablets are superpotent while others are subpotent. Affected lots expire July 2025; patients should contact their healthcare provider.
Viatris Inc. is recalling 19,549 bottles of Levothyroxine Sodium 175 mcg tablets nationwide due to potency failures. Some tablets contain excessive active ingredient while others contain insufficient amounts.
Micro-X Ltd. is recalling five MICRO-X Rover Mobile X-ray Systems due to a timing defect that prevents adequate X-ray exposures. The 4 millisecond exposure time does not allow sufficient tolerance for diagnostic-quality imaging.
Hermes Medical Solutions is recalling Hybrid Recon software (versions 4.0.0x and 5.0.0) due to a potential software configuration issue that may cause incorrect alignment during SPECT/CT image reconstruction. The issue affects 778 systems in the U.S. and internationally.
Mylan Institutional is recalling 2,835 cartons of Levothyroxine Sodium 100 mcg tablets nationwide due to potency deviations—some tablets may be underdosed while others may be overdosed.
Mylan Institutional is recalling Levothyroxine Sodium tablets nationwide due to subpotent and superpotent units. Patients taking affected tablets may receive incorrect doses of this thyroid medication.
Micro-X Ltd. is recalling 23 MICRO-X Rover Mobile X-ray Systems because the hand switch may be accidentally activated when dropped, causing the system to become unresponsive during patient imaging.
Ascend Laboratories is recalling Dabigatran Etexilate 150mg capsules due to elevated N-nitroso-Dabigatran impurity from a manufacturing deviation. Affected lots were distributed nationwide; consult your physician before making changes to your medication.